Chaperone-mediated autophagy in physiological homeostasis, disease and ageing
Chaperone-mediated autophagy (CMA) is a selective lysosomal degradation pathway. Recent insights into its regulation, substrate repertoire and therapeutic modulation have revealed organ-specific functions and highlighted CMA as a therapeutic target in ageing and disease.